Evidence map›Paper›PMID 39558543›Full record

ReviewJournal of surgical oncology2024

Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better?

Miguel E Alberto V, Daniela Zuluaga, Axel Winter, Johann Pratschke, Beate Rau, Safak Gül

Abstract readReview
In one paragraph

Review in Journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miguel E Alberto VSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-6249-6932
Daniela ZuluagaSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Axel WinterSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Johann PratschkeSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Beate RauSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Safak GülSurgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-1013-7126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main aim of this review is to analyze postoperative complications after cytoreductive surgery and intraperitoneal chemotherapy. Although the literature in this field is ever growing, reporting on complication is not a given. Nevertheless, some main risk factors such as prior surgery, high tumor burden and the center's expertize have an impact on patient outcomes. Transparency is key, if we want to continue to improve.

Indexed as

Cytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyPeritoneal NeoplasmsPostoperative ComplicationsHumansadverse eventscytoreductive surgeryHIPECmajor morbidityperitoneal surface malignanciespostoperative complications

Identifiers

PMID39558543
PMCPMC11826034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.